Peer Reviewed Medical
FY22 Technology/Therapeutic Development Award - Funding Level 2
The list of Fiscal Year 2022 Peer Reviewed Medical Research Program Technology/Therapeutic Development Award - Funding Level 2 applications recommended for funding is for informational purposes only. Identification on this list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
Institution | Principal Investigator |
---|---|
AcuraStem, Inc. | Peter Sazani |
Ceria Therapeutics, Inc. | David Jackson |
DTx Pharma | Arthur Suckow |
FluGen, Inc. | Pamuk Bilsel |
Lungpacer Medical USA, Inc. | Matthew Gani |
Microvascular Therapeutics, LLC | Emmanuelle Meuillet |
Obsidio, Inc. | Karen Dubbin |
Olfax, LLC | Jonathan Beckwith |
Rejuvenation Technologies, Inc. | John Ramunas |
safeBVM Corporation | Prathamesh Prabhudesai |
The Geneva Foundation | Yansong Li |
The Ohio State University | Justin Baker |
University of California San Diego | Stephanie Cherqui |
University of Pittsburgh | Louis Falo |
Last updated Thursday, January 5, 2023